The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA: Curative test for COVID should be conducted per product label; FDA posts MEA final guidance; CMS eyes radiology quality measures; Ra Medical agrees to fines.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Atricure.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allscripts, Aposhealth, Caredx, Casa Schmidt, Centene, Henry Schein, Integra Lifesciences, Magellan Health, Nextgen Biomed, Scent Medical Technologies, Si-Bone, Smith & Nephew, Virtue Health, Wellsky.

New hires and promotions in the med-tech industry, including: Biolog-ID, Cognoptix, Cynosure, Samsara.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ambrx, Antengene, Arcturus, Atara, Ayala, Bioniz, BMS, Forge, Inozyme, Matinas, Opko, Passage, Pfizer, Provention.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaccine, Astrazeneca, Azurrx, Biocure, Bonus, Califia, Cheplapharm, Entheon, Epivax, First Wave, Generation, Heading, Hoth, Inovio, Lantern, Moderna, Novus, Oncorus, Symbasis, Taysha, Wize.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptinyx, Biohaven, Calithera, Dicerna, F-star, Harpoon, Insmed, Kaleido, Kendrion, Landos, Mei, Pandion, Wu, Tiziana.

Biopharmas raising money in public or private financings, including: Azurrx, Eyepoint, Inspiremed, Ocumension, Redx, Taiwan Liposome .

New hires and promotions in the biopharma industry, including: Adrenomed, Cassava, Celldex, Enzon, G1, Intravacc, Myovant, Neximmune, Pliant, Obseva.

Med-tech firms raising money in public or private financings, including: Greenbrook TMS, Helius Medical Technologies.